Company intelligence
Ananda Pharma Ltd
Proprietary MRX1 CBD oral formulation in clinical trials for the treatment of pain associated with endometriosis & CIPN
Pharmaceutical Manufacturing
London, GB
13 employees
Founded 2018
1 public signals
About Ananda Pharma Ltd
Developer of cannabinoid-based medicines for the treatment of complex, chronic, inflammatory pain conditions. Patent pending formulation being used in two fully funded Phase II RCTs at Edinburgh University. Sale of two cannabidiol formulations through UK based medical cannabis pharmacy networks. Please contact for more info.
Verified activity
Signals from Ananda Pharma Ltd
1 published signal